Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 amending Regulation (EU) No 37/2010 to classify the substance paromomycin as regards its maximum residue limit (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 11 February 2019.
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘paromomycin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Paromomycin Paromomycin All food producing species 500 μg/kg Muscle For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’. MRLs for liver and kidney do not apply to fin fish. Not for use in animals from which milk is produced for human consumption. Anti-infectious agents/Antibiotics’ 1 500 μg/kg Liver 1 500 μg/kg Kidney 200 μg/kg Eggs
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.